An interventional study of tranexamic acid and Epinephrine in Rotator Cuff Tears, sponsored by Haseki Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-13.
Sponsored by Haseki Training and Research Hospital · Not applicable, Interventional, and Basic science
The primary aim of this report is to determine whether there is a difference between Epinephrine and Tranexamic acid in providing visual clarity during arthroscopic rotator cuff tear repair.
734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.
This study's enrollment of 100 is above the median of 60 across 538 interventional studies indexed under Rotator Cuff Injuries.
Browse Rotator Cuff Injuries studies →Haseki Training and Research Hospital is the lead sponsor of 75 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Age > 18 years
Exclusion Criteria:
Age \< 18 years
tranexamic acid added to irrigation solution
Drug: tranexamic acid
epinephrine added to irrigation solution
Drug: Epinephrine
Tranexamic acid is added to the irrigation fluid used in arthroscopic shoulder surgery.
Also known as: TRANSAMINE %5 5 ml 250 mg
Epinephrine is added to the irrigation fluid used in arthroscopic shoulder surgery.
Also known as: ADRENALIN 0,5 mg/1 m
Visual analog scale
Visual analog scale will be rated by surgeon. While 0 is the worst score with no clear vision, 10 was noted as the best score for visual clarity.
Time frame: through study completion, an average of 2 year
total operating time
period in minutes from the time the arthroscope was inserted into the glenohumeral joint until the termination of the arthroscopic procedure
Time frame: through study completion, an average of 2 year
average mean arterial pressure
mean arterial pressure per operation.
Time frame: through study completion, an average of 2 year
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Haseki Training and Research Hospital